Hammerschlag MR et al. |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324650
|
Chu S et al. |
Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial. |
1992 |
J Clin Pharmacol |
pmid:1531484
|
Heifets LB et al. |
Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1532486
|
Guay DR and Craft JC |
Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis. |
1992 |
J. Intern. Med. |
pmid:1532615
|
Ruf B et al. |
Failure of clarithromycin in preventing toxoplasmic encephalitis in AIDS patients. |
1992 |
J. Acquir. Immune Defic. Syndr. |
pmid:1532831
|
Cynamon MH and Klemens SP |
Activity of azithromycin against Mycobacterium avium infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329622
|
Ruf B et al. |
Acquired resistance of MAI to clarithromycin. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1533999
|
Chonmaitree T et al. |
Effect of viral respiratory tract infection on outcome of acute otitis media. |
1992 |
J. Pediatr. |
pmid:1534364
|
Knothe H |
[Short-term therapy of acute respiratory and ORL infections with Clarithromycin]. |
1992 |
Z Gesamte Inn Med |
pmid:9022402
|
Neu HC |
New macrolide antibiotics: azithromycin and clarithromycin. |
1992 |
Ann. Intern. Med. |
pmid:1310839
|
Brown BA et al. |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317144
|
Chu SY et al. |
Absolute bioavailability of clarithromycin after oral administration in humans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387301
|
Yajko DM et al. |
Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387302
|
Cohen Y et al. |
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1332586
|
Sifrim D et al. |
Comparison of the effects of midecamycin acetate and clarithromycin on gastrointestinal motility in man. |
1992 |
Drugs Exp Clin Res |
pmid:1292916
|
Dautzenberg B |
[Treatment of atypical mycobacterium infections: current state and therapeutic perspectives]. |
1992 |
Rev Pneumol Clin |
pmid:1296257
|
Peters DH and Clissold SP |
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. |
1992 |
Drugs |
pmid:1379907
|
Calzolari E et al. |
The efficacy of clarythromycin (A-56268, TE-031) in the treatment of genital chlamydial infection. |
1992 |
Drugs Exp Clin Res |
pmid:1306155
|
Klemens SP et al. |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336945
|
Yajko DM |
In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment? |
1992 |
Res. Microbiol. |
pmid:1455069
|